First Hawaiian Bank Ligand Pharmaceuticals Inc Transaction History

First Hawaiian Bank

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Jul 15, 2019	SELL	$107.38 - $129.34 $9,127 - $10,993	-85 Closed	0 $0
Q1 2019 Apr 02, 2019	SELL	$105.93 - $142.47 $52,859 - $71,092	-499 Reduced 85.45%	85 $11,000
Q4 2018 Jan 11, 2019	BUY	$128.36 - $272.13 $13,862 - $29,390	108 Added 22.69%	584 $79,000
Q3 2018 Oct 16, 2018	BUY	$211.18 - $274.49 $100,521 - $130,657	476 New	476 $131,000

257

18.2M

26.8K

9.3K

Ticker LGND
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 16,882,800
Market Cap $1.88B
Description
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, focuses on developing or acquiring technologies that help pharmaceutical companies to discover and develop medicines worldwide. Its commercial programs include Kyprolis and Evomela, which are used to treat multiple myeloma; Veklury for the treatment of moderate or severe COVID-19;...

Get notified when there are updates to the investment portfolio of First Hawaiian Bank, based on Form 13F filings with the SEC.

Stay updated on First Hawaiian Bank with notifications on news.